- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07625826
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery: A Randomized Controlled Study
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Yun Wu
- Telefonnummer: 8613865958254
- E-mail: wuyunanyi@163.com
Studiesteder
-
-
Anhui
-
Hefei, Anhui, Kina
- Second Affiliated hospital of Anhui Medical University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Patients scheduled for elective open thyroid surgery
- ASA class I-II
- Voluntarily participate in the study and sign the informed consent form
Exclusion Criteria:
- Body Mass Index > 30 kg/m²
- Patients with unstable ischemic cardiomyopathy, pulmonary hypertension, poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure >180/100 mmHg)
- Hepatic or renal dysfunction
- History of oral, maxillofacial, neck, or airway surgery, or pathological structural alterations
- Respiratory diseases (COPD, asthma, inflammation, chronic cough)
- Patients with elevated intracranial pressure
- Patients undergoing repeat surgery
- History of allergy to the investigational drug used in the study
- Patients with psychiatric disorders or alcohol abuse (daily ethanol intake ≥40 g, or having experienced alcohol withdrawal within the past 6 months, or unable to control alcohol consumption)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: ESK iv group
After anesthesia induction, continue to administer esketamine by infusion at 0.1 mg/kg/h during the maintenance phase of anesthesia, and stop the infusion of esketamine during suturing.
|
After anesthesia induction, continue to administer esketamine by infusion at 0.1 mg/kg/h during the maintenance phase of anesthesia, and stop the infusion of esketamine during suturing.
|
|
Placebo komparator: CON group
After anesthetic induction, an equal amount of saline is continuously infused by pump during the maintenance phase of anesthesia, and the saline infusion is stopped during suturing;
|
After anesthetic induction, an equal amount of saline is continuously infused by pump during the maintenance phase of anesthesia, and the saline infusion is stopped during suturing;
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of coughing during tracheal extubation
Tidsramme: perioperative (From the awakening period to immediately after tracheal extubation)
|
2 point scales; 0=None; 0 = Did not occur; 1 = Occurred;
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Severity of coughing during tracheal extubation
Tidsramme: perioperative (From the awakening period to immediately after tracheal extubation)
|
4 grade scales; Grade 0: No choking cough; Grade 1: Single cough episode, considered mild choking cough; Grade 2: Intermittent cough, lasting less than 5 seconds, considered moderate choking cough; Grade 3: Continuous severe cough, lasting more than 5 seconds, considered severe choking cough.
The higher the degree, the worse it is.
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Agitation score during tube removal
Tidsramme: perioperative (From the awakening period to immediately after tracheal extubation)
|
3-level scale; 1: Awake and calm; 2: Mild agitation but can be comforted; 3: Moderate agitation, difficult to comfort; 4: Severe agitation, cannot be comforted; The higher the degree, the worse the situation.
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Blood pressure
Tidsramme: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
From the induction period until 5 minutes after the completion of surgery
|
|
Airway pressure 5 minutes after intubation and at the end of surgery
Tidsramme: 5 minutes after intubation and at the end of the surgery
|
5 minutes after intubation and at the end of the surgery
|
|
|
Intraoperative use rate and dosage of vasoactive drugs
Tidsramme: intraoperative (From the induction period to the end of anesthesia)
|
intraoperative (From the induction period to the end of anesthesia)
|
|
|
Sore throat score
Tidsramme: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
4-point scales; 0 = None; 1 = Mild, milder than a common cold; 2 = Moderate, like a sore throat from a common cold; 3 = Severe, more severe than a common cold; The higher the score, the greater the level of pain.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
|
Hoarseness scores
Tidsramme: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
4-point scores; 0 = None; 1 = Transient hoarseness occurs; 2 = Patient perceives hoarseness during visit; 3 = Hoarseness is clearly noticeable; The higher the score, the more severe the hoarseness.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
|
Surgical area pain scores
Tidsramme: Postoperative day 1 and day 2
|
Pain NRS scale score: 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain.
The higher the score, the more severe the pain.
|
Postoperative day 1 and day 2
|
|
Incidence of adverse reactions within 48 hours postoperatively
Tidsramme: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative nausea and vomiting(PONV) score
Tidsramme: Within day 2 after surgery
|
Vomiting: 0 = None; 1 = Once; 2 = Twice; 3 = Three times or more Nausea, does it affect daily life: 0 = None; 1 = Sometimes; 2 = Often; 3 = Always |
Within day 2 after surgery
|
|
Postoperative analgesic dosage
Tidsramme: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative time to first food
Tidsramme: perioperative (Time from returning to the ward to the first food)
|
perioperative (Time from returning to the ward to the first food)
|
|
|
Upper Aerodigestive Symptoms After Thyroidectomy (UADS) questionnaire score
Tidsramme: Three month after surgery
|
Upper Aerodigestive Symptoms After Thyroidectomy Questionnaire; Instructions: 0=No problem, 1=Minor, 2=Moderate, 3=Major. Voice symptoms
|
Three month after surgery
|
|
Heart rate
Tidsramme: Time Frame: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
Time Frame: From the induction period until 5 minutes after the completion of surgery
|
|
Oxygen saturation
Tidsramme: Time Frame: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
Time Frame: From the induction period until 5 minutes after the completion of surgery
|
|
Anesthesia time
Tidsramme: perioperative (Time from induction to discontinuation of anesthetic agents)
|
perioperative (Time from induction to discontinuation of anesthetic agents)
|
|
|
Surgery time
Tidsramme: From the start of surgery to the end of surgery
|
From the start of surgery to the end of surgery
|
|
|
Extubation time
Tidsramme: perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
|
|
Duration of tracheal tube placement
Tidsramme: perioperative (Time from intubation to )
|
perioperative (Time from intubation to )
|
|
|
Awakening time
Tidsramme: perioperative (Stop the anesthesia drug injection until awakening time)
|
perioperative (Stop the anesthesia drug injection until awakening time)
|
|
|
Post-anesthesia care unit (PACU) stay time
Tidsramme: perioperative (Duration from entering the PACU to leaving the PACU)
|
perioperative (Duration from entering the PACU to leaving the PACU)
|
|
|
PACU RASS score
Tidsramme: perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room.)
|
|
perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room.)
|
|
Intraoperative doses of propofol
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of remifentanil
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of sufentanil
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative fluid volume
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative blood loss
Tidsramme: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Sleep scores
Tidsramme: Postoperative 24 hours and 48 hours
|
4 point scores; 1 = Good sleep; 2 = Restless sleep; 3 = Dreamy sleep; 4 = Insomnia; The higher the score, the poorer the sleep.
|
Postoperative 24 hours and 48 hours
|
|
Antiemetic drug dosage
Tidsramme: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative time to ambulation
Tidsramme: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Length of postoperative hospital stay
Tidsramme: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Postoperative time to first water intake
Tidsramme: Perioperative (Time from returning to the ward to the first drink of water)
|
Perioperative (Time from returning to the ward to the first drink of water)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- YX2026-124
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Esketamine
-
Riccardo GuglielmoRekrutteringAnhedonia | Angst | Erkendelse | Apati | Temperament | Psykiatriske komorbiditeter | Depression og livskvalitet | Behandlingsresistent depression (TRD)Italien
-
Janssen Research & Development, LLCAfsluttetBehandlingsresistent depressiv lidelseForenede Stater, Japan, Belgien
-
Qinghai UniversityQinghai Red Cross HospitalIkke rekrutterer endnuFødselsdepression
-
Celon Pharma SANational Center for Research and Development, PolandAfsluttet
-
Peking University First HospitalTianjin Medical University General HospitalIkke rekrutterer endnuPostoperativt delirium | Ældre | Ikke-kardial kirurgi | Esketamin | Forsinket neurokognitiv genopretningKina
-
Janssen Research & Development, LLCAfsluttetSund og raskForenede Stater
-
Janssen Pharmaceutical K.K.Afsluttet
-
Celon Pharma SANational Center for Research and Development, PolandAfsluttetStørre depressiv lidelsePolen
-
University of Sao PauloRekruttering
-
Janssen Korea, Ltd., KoreaRekrutteringDepressiv lidelse, behandlingsresistentSydkorea